Mayo Clinic News Network
Think of glutathione as a cellular bodyguard
Wu D, Liu J, Zhou C, Ma W, Zhou L, Ge Y, et al
17 Randomized placebo-controlled trials have noted L-arginine, at doses of 1.52.4 grams per day, led to a small but significant positive impact on symptoms in some patients with IC/BPS
Low investment, high returns, complete marketing support
Further mechanism studies showed that after transfection of miR-1338 inhibitor, OJP promoted the secretion of NO, inducible iNOS and postoperative delirium (POD), improved phagocytosis and cell migration, increased the expression of mRNA and protein of toll-like receptor4 (TLR4), myeloid differentiation primary response gene 88 (MyD88), inhibitor of kappa B kinase (IKK ) and NF-B, and inhibited cell apoptosis and ROS secretion